Skip to main content
Premium Trial:

Request an Annual Quote

Mike Guerra

California Life Sciences Association has appointed Mike Guerra as its CEO and president, effective January 7th. He will succeed Sara Radcliffe, who will be departing the firm to pursue new opportunities. Guerra previously served as VP of the Americas for Avidity Science. In addition, he has held senior leadership positions with VWR International over the last 14 years. His last role at VWR was VP of sales for the western region of the US. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.